SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dalia El-Lebedy, Enas Rasheed, Mona Kafoury, Dalia Abd-El Haleem, Eman Awadallah, Ingy Ashmawy, Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus, Journal of Diabetes and its Complications, 2016, 30, 4, 580

    CrossRef

  2. 2
    Wijtske Annema, Arnold von Eckardstein, Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy, Translational Research, 2016,

    CrossRef

  3. 3
    Kun-Ling Tsai, Yuh-Lih Chang, Po-Hsun Huang, Yung-Hsin Cheng, Ding-Hao Liu, Hsiao-Yun Chen, Chung-Lan Kao, Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells, Journal of Vascular Surgery, 2016, 63, 1, 204

    CrossRef

  4. 4
    F. Montecucco, V. Braunersreuther, F. Burger, S. Lenglet, G. Pelli, F. Carbone, R. Fraga-Silva, N. Stergiopulos, C. Monaco, C. Mueller, S. Pagano, F. Dallegri, F. Mach, N. Vuilleumier, Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4, Thrombosis and Haemostasis, 2015, 114, 2, 410

    CrossRef

  5. 5
    Javier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, Francisco J. Ballina-García, Francisco Abal, Ana Suárez, Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients, Translational Research, 2015, 166, 6, 529

    CrossRef

  6. 6
    Priscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier, Paul Cutler, Biomarkers for cardiovascular risk assessment in autoimmune diseases, PROTEOMICS - Clinical Applications, 2015, 9, 1-2
  7. 7
    J. C. Mason, P. Libby, Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions, European Heart Journal, 2015, 36, 8, 482

    CrossRef

  8. 8
    Maria Rubini Gimenez, Sabrina Pagano, Julien Virzi, Fabrizio Montecucco, Raphael Twerenbold, Tobias Reichlin, Karin Wildi, Daniel Grueter, Cedric Jaeger, Philip Haaf, Nicolas Vuilleumier, Christian Mueller, Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction, European Journal of Clinical Investigation, 2015, 45, 4
  9. 9
    Sara Croca, Paul Bassett, Sharon Chambers, Maria Davari, Karim Alber, Oliver Leach, Yiannis Ioannou, Ian Giles, David Isenberg, Anisur Rahman, IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study, Arthritis Research & Therapy, 2015, 17, 1, 26

    CrossRef

  10. 10
    Federico Carbone, Fabrizio Montecucco, Inflammation in arterial diseases, IUBMB Life, 2015, 67, 1
  11. 11
    M. M. Radwan, D. El-Lebedy, R. Fouda, E. Elsorougy, D. Fakhry, Anti-apolipoprotein A-1 antibodies and carotid intima–media thickness in Egyptian women with systemic lupus erythematosus, Clinical Rheumatology, 2014, 33, 4, 493

    CrossRef

  12. 12
    Jenny Amaya-Amaya, Laura Montoya-Sánchez, Adriana Rojas-Villarraga, Cardiovascular Involvement in Autoimmune Diseases, BioMed Research International, 2014, 2014, 1

    CrossRef

  13. 13
    P. A. Wick, A. Mombelli, S. Pagano, X. Moren, C. Giannopoulou, F. Mach, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis, Journal of Periodontal Research, 2013, 48, 3
  14. 14
    P. Roux-Lombard, S. Pagano, F. Montecucco, N. Satta, N. Vuilleumier, Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases, Clinical Reviews in Allergy & Immunology, 2013, 44, 1, 84

    CrossRef

  15. 15
    F. Carbone, A. Nencioni, F. Mach, N. Vuilleumier, F. Montecucco, Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases, Thrombosis and Haemostasis, 2013, 109, 5, 854

    CrossRef

  16. 16
    Jenny Amaya-Amaya, Juan Camilo Sarmiento-Monroy, Ruben-Dario Mantilla, Ricardo Pineda-Tamayo, Adriana Rojas-Villarraga, Juan-Manuel Anaya, Novel risk factors for cardiovascular disease in rheumatoid arthritis, Immunologic Research, 2013, 56, 2-3, 267

    CrossRef

  17. 17
    N. Vuilleumier, F. Montecucco, G. Spinella, S. Pagano, M. Bertolotto, B. Pane, A. Pende, K. Galan, P. Roux-Lombard, C. Combescure, F. Dallegri, F. Mach, D. Palombo, Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy, Thrombosis and Haemostasis, 2013, 109, 4, 706

    CrossRef

  18. 18
    J. Michelle Kahlenberg, Mariana J. Kaplan, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  19. 19
    Alessandra Quercioli, Fabrizio Montecucco, Katia Galan, Osman Ratib, Pascale Roux-Lombard, Sabrina Pagano, François Mach, Thomas H. Schindler, Nicolas Vuilleumier, Anti-Apolipoprotein A-1 IgG Levels Predict Coronary Artery Calcification in Obese but Otherwise Healthy Individuals, Mediators of Inflammation, 2012, 2012, 1

    CrossRef

  20. 20
    S. Pagano, N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex, Journal of Internal Medicine, 2012, 272, 4
  21. You have free access to this content21
    C. Mueller, Auto-antibodies: diagnostic tools in acute myocardial infarction?, Journal of Internal Medicine, 2012, 271, 5
  22. You have free access to this content22
    P.-F. Keller, S. Pagano, P. Roux-Lombard, P. Sigaud, O. T. Rutschmann, F. Mach, D. Hochstrasser, N. Vuilleumier, Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction, Journal of Internal Medicine, 2012, 271, 5
  23. 23
    P. C. Teixeira, P. Cutler, N. Vuilleumier, Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  24. 24
    Axel Finckh, Delphine S. Courvoisier, Sabrina Pagano, Sylvette Bas, Paola Chevallier-Ruggeri, Denis Hochstrasser, Pascale Roux-Lombard, Cem Gabay, Nicolas Vuilleumier, Evaluation of cardiovascular risk in patients with rheumatoid arthritis: Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?, Arthritis Care & Research, 2012, 64, 6
  25. 25
    Menno Pruijm, Jan Schmidtko, Anthony Aho, Sabrina Pagano, Pascale Roux-Lombard, Daniel Teta, Michel Burnier, Nicolas Vuilleumier, High Prevalence of Anti-Apolipoprotein/A-1 Autoantibodies in Maintenance Hemodialysis and Association With Dialysis Vintage, Therapeutic Apheresis and Dialysis, 2012, 16, 6
  26. 26
    Delphine Michel-Monigadon, Sabine Steffens, Filippo Molica, François Mach, Fabrizio Montecucco, Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology, Expert Review of Cardiovascular Therapy, 2012, 10, 12, 1481

    CrossRef

  27. 27
    F. Montecucco, N. Vuilleumier, S. Pagano, S. Lenglet, M. Bertolotto, V. Braunersreuther, G. Pelli, E. Kovari, B. Pane, G. Spinella, A. Pende, D. Palombo, F. Dallegri, F. Mach, P. Roux-Lombard, Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability, European Heart Journal, 2011, 32, 4, 412

    CrossRef

  28. 28
    Katja Lakota, Polona Zigon, Katjusa Mrak-Poljsak, Blaz Rozman, Yehuda Shoenfeld, Snezna Sodin-Semrl, Antibodies against acute phase proteins and their functions in the pathogenesis of disease: A collective profile of 25 different antibodies, Autoimmunity Reviews, 2011, 10, 12, 779

    CrossRef